Neurofibromatosis and Schwannomatosis Program

With a deep expertise in Neurofibromatosis 1 (NF1), NF2-related schwannomatosis (NF2), and other forms of schwannomatosis, our dedicated program provides comprehensive care to patients diagnosed with these tumor predisposition syndromes. Collaborating with our colleagues at the Children’s Hospital, we focus on safe and patient-centric transition from pediatric to adult care. We hold the distinction of Comprehensive Center for NF1 and Comprehensive Center for Schwannomatosis from the Children’s Tumor Foundation, which is the highest level of recognized clinical expertise. Further, as an invited site for the Department of Defense-funded NF Clinical Trials Consortium, we offer innovative therapies to patients in our center.